PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-10-17 (2)

Date Title Company
17-Oct-2023 Babies with a low birthweight are four times more likely to develop fatty liver disease in later life, new study shows , United European Gastroenterology (UEG)
17-Oct-2023 Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells The Institute of Cancer Research
17-Oct-2023 Amolyt Pharma Announces Data on Prevalence of Bone Disease in Patients with Hypoparathyroidism and Favorable Bone Effects of Eneboparatide at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting Amolyt Pharma
17-Oct-2023 Theriva™ Biologics Announces Presentation at ESMO Congress 2023 Featuring Survival Outcomes in Phase 1 Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck Theriva™ Biologics, Inc
17-Oct-2023 Fighting Counterfeiting in the Medical and Pharmaceutical Industry: Origify offers End-to-End Authentication Bosch
17-Oct-2023 PharmaKure announces study success for novel blood test to identify biomarkers in patients with Alzheimer’s Disease PharmaKure
17-Oct-2023 New publication shows XF-73 drug potent against 2,527 Staphylococcus isolates Largest study of its kind to date demonstrates effectiveness of XF-73 against all tested antibiotic resistant strains Destiny Pharma
17-Oct-2023 PureTech to Present at Two Upcoming Investor Conferences PureTech Health
17-Oct-2023 Cell Line Engineering Breakthrough Cuts Drug Development Times by Up To 12 Months Promega Corporation
17-Oct-2023 Moberg Pharma’s Nomination Committee appointed Moberg Pharma
17-Oct-2023 SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease SpliceBio
17-Oct-2023 Poolbeg Pharma Partners with a Nasdaq-Listed Biopharma Company on its Oral Delivery Platform Poolbeg Pharma
17-Oct-2023 Tessellate BIO Emerges from Stealth The Next Generation Synthetic Lethality Precision Oncology Company Tessellate BIO
17-Oct-2023 Lytix Biopharma granted up to NOK14.3m (US$1.3m) of public non-dilutive funding from ’SkatteFUNN’ Lytix Biopharma
17-Oct-2023 STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics STORM Therapeutics Ltd
17-Oct-2023 Manual programming preventing rapid rollout of robots for over half of UK manufacturers Visual Components
17-Oct-2023 Myricx Bio to Present Preclinical Data Validating NMTi as a Novel ADC Payload Class Myricx Bio
17-Oct-2023 Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam Abcam plc
17-Oct-2023 PATIENTS DOSED WITH METHYLONE IN LONDON IN NEW CLINICAL TRIAL TO TREAT PTSD Clerkenwell Health
17-Oct-2023 Cherwell to participate in sterile product manufacturing think tank discussions Cherwell